UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
Current Report Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
March 1, 2010
 
Date of Report (Date of earliest event reported)
OSI PHARMACEUTICALS, INC.
 
(Exact name of registrant as specified in its charter)
         
Delaware   0-15190   13-3159796
         
(State or other jurisdiction of
incorporation) 		  (Commission
File Number) 		  (I.R.S. Employer
Identification No.)
41 Pinelawn Road Melville, NY 11747
 
(Address of principal executive offices)
(631) 962-2000
 
(Registrant’s telephone number, including area code)
N/A
 
(Former name or former address,
if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 

 

Item 8.01.   Other Events .
     On March 1, 2010, OSI Pharmaceuticals, Inc. (“OSI”) issued a press release confirming receipt of an unsolicited proposal from Astellas Pharma Inc. to acquire OSI. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
Item 9.01.   Financial Statements and Exhibits.
     
Exhibit No.   Description
99.1
  Press release dated March 1, 2010.

-2-

 

SIGNATURE
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
Date: March 1, 2010   OSI PHARMACEUTICALS, INC.
  		 
  By:   /s/ Barbara A. Wood    
    Barbara A. Wood   
    Senior Vice President, General
Counsel and Secretary  		 

-3-

 

         
EXHIBIT INDEX
     
Exhibit No.   Description
99.1
  Press release dated March 1, 2010.

-4-

Osi Pharmaceuticals (NASDAQ:OSIP)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Osi Pharmaceuticals Charts.
Osi Pharmaceuticals (NASDAQ:OSIP)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Osi Pharmaceuticals Charts.